1. Pink Sheet

Pakistan Steps Up Pharmacovigilance

New Guidance Implements More Robust Drug Surveillance

 
• By Neena Brizmohun

A new guidance document explains how Pakistan’s revamped pharmacovigilance system will work.

Pakistan
Pakistan is ramping up its safety surveillance of therapeutic products • Source: Shutterstock

The Drug Regulatory Authority of Pakistan has issued a guidance document designed to implement a more robust pharmacovigilance program for monitoring the safety of medicines and other therapeutic goods in the pre- and post-marketing settings.

In line with Pakistan’s National Health Vision 2016-2025, the program aims to establish “vibrant pharmacovigilance centres at national level and collecting points at provincial level,” says the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Drug Safety

More from Pink Sheet

Trump Administration Push For Dismissal, Transfer Of Mifepristone Case Leaves Overhang For Pharma

 
• By Sarah Karlin-Smith

The Trump Administration requested a dismissal or transfer of a lawsuit seeking to tighten the safety requirements for the abortion pill mifepristone on procedural grounds, which still leaves the administration's position on the case's merits unclear.

Opioid Safety: US FDA Hears Mixed Messages On Adding Posmarketing Studies To Labeling

 
• By Sue Sutter

Some advisory committee members said adding quantitative data on misuse, abuse, opioid use disorder and overdose to labeling would be helpful, but others worried the two epidemiological studies were not sufficiently generalizable to a broader population.

Viatris Agrees To $335m Opioid Settlement Ending US State, Local Government Cases

 
• By Dean Rudge

Viatris joined Hikma and Amneal, in signing agreements for cash settlements that resolve allegations its practices fueled the US’ deadly opioid epidemic.